Shearman & Sterling represented BofA Merrill Lynch, Goldman, Sachs & Co. and J.P. Morgan Securities as joint bookrunning managers and representatives of the several underwriters in connection with a public offering of $1.5 billion aggregate principal amount of senior notes of Life Technologies Corporation. Life Technologies Corporation is a global biotechnology tools company that provides its customers with systems and reagents that enable a broad spectrum of biological research of genes, proteins and cells within academic and life science research and commercial applications.